Today: 27 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Bloom Energy stock turns choppy as SEC filing details Oracle warrant and Brookfield AI financing

Bloom Energy stock turns choppy as SEC filing details Oracle warrant and Brookfield AI financing

Bloom Energy shares fell 0.8% to $153.99 in midday trading Tuesday after disclosing a Brookfield-backed $5 billion financing framework and a potential Oracle warrant for up to 3.53 million shares at $113.28. The company’s annual filing showed 2025 revenue up 37% to $2.02 billion, with a net loss despite positive operating income.
10 February 2026
·······
Kenvue stock pops today: what KVUE investors are watching into earnings and the Kimberly-Clark deal

Kenvue stock pops today: what KVUE investors are watching into earnings and the Kimberly-Clark deal

Kenvue shares rose 1.8% to $18.50 Tuesday, tracking gains in Kimberly-Clark after shareholders approved a cash-and-stock takeover valuing Kenvue at about $19.10 per share. Kenvue’s dividend record date is Feb. 11, with quarterly results due Feb. 17. The deal is expected to close in the second half of 2026, pending regulatory approval.
10 February 2026
···
CyberArk stock hovers near $410 as Nasdaq flags Feb. 10 halt ahead of Palo Alto merger close

CyberArk stock hovers near $410 as Nasdaq flags Feb. 10 halt ahead of Palo Alto merger close

CyberArk shares rose 0.3% to $410.32 midday Tuesday after Nasdaq said trading will halt after hours as Palo Alto Networks moves to close its takeover. The deal, set to close before markets open Feb. 11, offers CyberArk holders $45 in cash and 2.2005 Palo Alto shares per share. The implied value stood near $412, with a $1.75 spread. Palo Alto shares also edged higher.
10 February 2026
···
Merck stock price slips after insider sale filings; what MRK investors are watching next

Merck stock price slips after insider sale filings; what MRK investors are watching next

Merck shares fell 0.5% to $117.01 after SEC filings showed insider stock sales by two executives on Feb. 9. Chief Marketing Officer Chirfi Guindo sold 10,000 shares; Executive Vice President Jennifer Zachary exercised and sold 121,573 shares. The moves followed a revenue forecast below Wall Street estimates. Merck underperformed the broader market and sector peers.
10 February 2026
··
Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next

Wells Fargo & Company stock drops 2% as CFO talks loan growth — what traders watch next

Wells Fargo shares fell about 2% to $92.69 Tuesday, reversing from a session high of $94.98. CFO Mike Santomassimo told an investor conference the bank expects 2026 loan growth from credit cards and autos as mortgages stabilize. The drop outpaced other major banks as markets awaited U.S. jobs and inflation data due later this week. Wells Fargo reports Q1 results April 14.
10 February 2026
·
Mastercard stock price rebounds after retail sales stall; MA investors eye Wednesday jobs report

Mastercard stock price rebounds after retail sales stall; MA investors eye Wednesday jobs report

Mastercard shares climbed 1.4% to $542.87 by midday Tuesday, rebounding after a 2.44% drop Monday. U.S. December retail sales were flat, sending Treasury yields lower and boosting bets on Federal Reserve rate cuts. Mastercard announced a new e-commerce logistics partnership in Egypt with Bosta targeting small businesses. Visa and American Express shares also rose.
10 February 2026
·
Cisco stock rises after Silicon One G300 AI chip launch, with earnings next

Cisco stock rises after Silicon One G300 AI chip launch, with earnings next

Cisco shares rose 0.7% to $87.35 Tuesday after the company unveiled its Silicon One G300 AI networking chip and new router, targeting data-center customers. The G300, built on TSMC’s 3-nanometer process, is set for release in the second half of 2026. Investors await Cisco’s quarterly update later this week. Rival stocks Nvidia and Broadcom slipped during the session.
10 February 2026
····
Goldman Sachs stock rises as Solomon says private-equity deals are starting to “accelerate”

Goldman Sachs stock rises as Solomon says private-equity deals are starting to “accelerate”

Goldman Sachs shares rose 0.6% to $949.59 Tuesday, outperforming financial-sector ETFs as CEO David Solomon said private equity sponsors face pressure to return capital, spurring deal activity. Solomon expects strategic M&A to be “meaningfully higher” than recent years. Investors await key U.S. jobs and inflation data later this week. The 10-year Treasury yield edged down to 4.184%.
10 February 2026
·
IREN stock price slips after Monday surge as bitcoin miners refocus on its Microsoft AI bet

IREN stock price slips after Monday surge as bitcoin miners refocus on its Microsoft AI bet

IREN shares fell 1.6% to $45.42 Tuesday morning, following a 10.3% rebound Monday. The bitcoin miner and AI cloud operator reported a Q4 net loss of $155.4 million on $184.7 million revenue, as AI cloud revenue rose to $17.3 million. IREN secured $3.6 billion in GPU financing for its Microsoft contract. Bitcoin traded near $69,405, while other U.S.-listed miners edged higher.
10 February 2026
·········
Western Digital stock price slides 7% as WDC leads Nasdaq decliners — what traders watch next

Western Digital stock price slides 7% as WDC leads Nasdaq decliners — what traders watch next

Western Digital shares fell 7.5% to $264.50 in late morning trading Tuesday after a new SEC filing showed the company moved to redeem its 2026 senior notes. The stock underperformed storage peers as U.S. retail sales data and sector downgrades pressured tech names. Seagate and Micron also declined. Western Digital remains up about 57% year to date despite the drop.
10 February 2026
·
Salesforce stock swings higher after job-cut report as earnings near: what investors watch next

Salesforce stock swings higher after job-cut report as earnings near: what investors watch next

Salesforce shares rose about 1% Tuesday after reports the company cut fewer than 1,000 jobs earlier this month, according to Business Insider. The layoffs reportedly affected marketing, product management, data analytics, and Agentforce AI teams. Salesforce has not commented. Investors await the company’s Feb. 25 earnings for updates on growth, costs, and AI strategy.
10 February 2026
···
Chevron stock slips as Tengiz field ramps back up, oil traders eye Iran risk

Chevron stock slips as Tengiz field ramps back up, oil traders eye Iran risk

Chevron shares slipped 0.3% to $182.08 in midday trading as the Tengiz oilfield in Kazakhstan, led by Chevron, recovered to 60% of peak output after January fires. Tengiz aims to reach 950,000 barrels per day by Feb. 23, up from 550,000 bpd on Feb. 8, according to industry sources. Oil prices held steady. Traders are awaiting U.S. inventory data and further updates on Tengiz.
10 February 2026
····
ServiceNow stock rebounds nearly 4% as AI-fueled software jitters ease — for now

ServiceNow stock rebounds nearly 4% as AI-fueled software jitters ease — for now

ServiceNow shares climbed 3.6% to $107.66 Tuesday after recent sharp declines, as software stocks rebounded from last week’s selloff. Retail inflows into BlackRock’s tech-software ETF reached a record $176 million, even as the S&P 500 software index remains down 13% since late January. Broader markets were mixed following flat December U.S. retail sales data. Datadog rose after beating quarterly estimates but issued cautious full-year guidance.
10 February 2026
··
1 … 123 124 125 126 127 … 755

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Go toTop